Splice-variant-specific effects of primary aldosteronism point mutations on human CaV3.2 calcium channels

Min He1, Zilan Xu1, Yuchen Zhang1

  • 1Department of Physiology and Biophysics, School of Life Sciences, Institutes of Brain Science, Fudan University, Shanghai, China.

Cell Calcium
|November 10, 2019
PubMed

Insights

Four CACNA1H gene mutations cause primary aldosteronism by altering CaV3.2(+26) channel function. These mutations primarily impact the long splice variant, explaining their specific clinical effects.

Area of Science:

  • Molecular biology
  • Channelopathies
  • Endocrinology

Background:

  • CaV3.2 calcium channels are crucial for neural excitability and aldosterone secretion.
  • Four germline mutations in CACNA1H (CaV3.2 channels) are linked to primary aldosteronism (PA).
  • The M1549I mutation additionally causes neural malfunctions, suggesting variant-specific effects.

Purpose of the Study:

  • To investigate the expression of CACNA1H splice variants in human adrenal zona glomerulosa (ZG) cells.
  • To determine the functional consequences of four PA-associated mutations on CaV3.2(-26) and CaV3.2(+26) channel variants.

Main Methods:

  • Analysis of CACNA1H splice variant expression in human ZG cells.
  • Electrophysiological characterization of CaV3.2(-26) and CaV3.2(+26) channels with S196L, M1549I, V1951E, and P2083L mutations.

Main Results:

  • Human ZG cells exclusively express the long CaV3.2(+26) splice variant.
  • M1549I mutation significantly slowed CaV3.2(+26) inactivation ( >5-fold) and CaV3.2(-26) inactivation (>2-fold).
  • S196L, V1951E, and P2083L mutations accelerated CaV3.2(+26) recovery from inactivation but not CaV3.2(-26).
  • All four mutations induced a gain-of-function in CaV3.2(+26) channels, leading to aldosterone overproduction.

Conclusions:

  • The four PA mutations exert more significant functional changes on CaV3.2(+26) than CaV3.2(-26) channels.
  • The limited effect of S196L, V1951E, and P2083L mutations on CaV3.2(-26) electrophysiology may explain their phenotype restriction to PA.

Related Concept Videos

Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
1.5K
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
2.1K
Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
10.1K
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
1.2K
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.9K
Mutations01:39

Mutations

Overview
94.2K